Article

QPSOBT: One codon usage optimization software for protein heterologous expression

Key Laboratory of Industrial Biotechnology, School of Biotechnology, JiangNan University, 214122, Wuxi, Jiangsu, China
Journal of Bioinformatics and Sequence Analysis 07/2010; 2:25-29.

ABSTRACT QPSOBT is a codon usage optimization software based on the Quantum-behaved Particle Swarm Optimization (QPSO) algorithm. It can design synthetic genes of multikilobase sequences for protein heterologous expression rapidly. The program runs on .NET platform. Compared to the existing codon optimization software and web services, QPSOBT is able to generate better results when DNA/RNA sequence length is less than 6 kb which is a commonly-used range, especially when some restriction sites need to be removed. QPSOBT is freely available (www.sigcib.org/qpsobt.html).

Download full-text

Full-text

Available from: Yujie Cai, Oct 08, 2014
1 Follower
 · 
631 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pigment epithelium-derived factor (PEDF) is widely known for its neurotrophic and antiangiogenic functions. Efficacy studies of PEDF in animal models are limited because of poor heterologous protein yields. Here, we redesigned the human PEDF gene to preferentially match codon frequencies of E coli without altering the amino acid sequence. Following de novo synthesis, codon optimized PEDF (coPEDF) and the wtPEDF genes were cloned into pET32a containing a 5' thioredoxin sequence (Trx) and the recombinant Trx-coPEDF or Trx-wtPEDF fusion constructs expressed in native and two tRNA augmented E coli hosts - BL21-CodonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP, carrying extra copies of tRNAarg,ile,leu and tRNAarg,pro genes, respectively. Trx-PEDF fusion proteins were isolated using Ni-NTA metal affinity chromatography and PEDF purified after cleavage with factor Xα. Protein purity and identity were confirmed by western blot, MALDI-TOF, and UV/CD spectral analyses. Expression of the synthetic gene was ∼3.4 fold greater (212.7 mg/g; 62.1 mg/g wet cells) and purified yields ∼4 fold greater (41.1 mg/g; 11.3 mg/g wet cell) than wtPEDF in the native host. A small increase in expression of both genes was observed in hosts supplemented with rare tRNA genes compared to the native host but expression of coPEDF was ∼3 fold greater than wtPEDF in both native and codon-bias-adjusted E coli strains. ΔGs at -3 to +50 of the Trx site of both fusion genes were -3.9 kcal/mol. Functionally, coPEDF was equally as effective as wtPEDF in reducing oxidative stress, promoting neurite outgrowth, and blocking endothelial tube formation. These findings suggest that while rare tRNA augmentation and mRNA folding energies can significantly contribute to increased protein expression, preferred codon usage, in this case, is advantageous to translational efficiency of biologically active PEDF in E coli. This strategy will undoubtedly fast forward studies to validate therapeutic utility of PEDF in vivo.
    PLoS ONE 11/2010; 5(11):e15056. DOI:10.1371/journal.pone.0015056 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: H I G H L I G H T S c Developed in silico rational framework for synthetic terpenoid production. c Updated metabolic model of A. thaliana to describe terpenoid biosynthesis. c Analyzed heterologous expression of A. thaliana pathways in microbial systems. c Proposed novel in silico method of cofactor modification analysis. c Improve terpenoid yield by modifying enzyme cofactor specificity. a b s t r a c t Terpenoids are a large and diverse group of plant secondary metabolites with important applications in the pharmaceutical, cosmetic and food industries. However, low yields obtained from natural plant sources necessitate the search for alternative ways to increase the throughput of terpenoid production. Thus, fast-growing microbial systems, such as Escherichia coli and Saccharomyces cerevisiae, can be genetically engineered to achieve high productivity by systematically designing terpenoid synthetic routes and improving its precursor, isopentenyl diphosphate (IPP) production. To this end, we develop an in silico model-based rational framework where the cellular metabolism in natural terpenoid producer is analyzed to provide a basis for designing its synthetic pathways in microbial hosts. At the outset, we updated the genome-scale Arabidopsis thaliana metabolic model to characterize optimal metabolic utilization patterns that were subsequently incorporated into the in silico models of microbial hosts for improving terpenoid yield. We also developed a novel computational approach, cofactor modification analysis (CMA), to tackle potential limitations in terpenoid production caused by suboptimal balance of the different redox cofactors. The enzyme targets identified by CMA can potentially lead to better metabolic engineering strategies for enhancing terpenoid production in microbial systems.
    Chemical Engineering Science 09/2012; 103. DOI:10.1016/j.ces.2012.09.006 · 2.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene expression is closely related to optimal vector-host system pairing in many prokaryotes. Redesign of the human cystatin C (cysC) gene using the preferred codons of the prokaryotic system may significantly increase cysC expression in Escherichia coli (E. coli). Specifically, cysC expression may be increased by removing unstable sequences and optimizing GC content. According to E. coli expression system codon preferences, the gene sequence was optimized while the amino acid sequence was maintained. The codon-optimized cysC (co-cysC) and wild-type cysC (wt-cysC) were expressed by cloning the genes into a pET-30a plasmid, thus transforming the recombinant plasmid into E. coli BL21. Before and after the optimization process, the prokaryotic expression vector and host bacteria were examined for protein expression and biological activation of CysC. The recombinant proteins in the lysate of the transformed bacteria were purified using Ni(2+)-NTA resin. Recombinant protein expression increased from 10% to 46% based on total protein expression after codon optimization. Recombinant CysC purity was above 95%. The significant increase in cysC expression in E. coli expression produced by codon optimization techniques may be applicable to commercial production systems.
    BioMed Research International 10/2012; 2012:732017. DOI:10.1155/2012/732017 · 2.71 Impact Factor